Related references
Note: Only part of the references are listed.Adhesion/growth-regulatory galectins tested in combination: evidence for formation of hybrids as heterodimers
Michelle C. Miller et al.
BIOCHEMICAL JOURNAL (2018)
Monosaccharide Derivatives with Low-Nanomolar Lectin Affinity and High Selectivity Based on Combined Fluorine-Amide, Phenyl-Arginine, Sulfur-pi, and Halogen Bond Interactions
Fredrik R. Zetterberg et al.
CHEMMEDCHEM (2018)
Galectin-3 pharmacological inhibition attenuates early renal damage in spontaneously hypertensive rats
Ernesto Martinez-Martinez et al.
JOURNAL OF HYPERTENSION (2018)
Systematic Tuning of Fluoro-galectin-3 Interactions Provides Thiodigalactoside Derivatives with Single-Digit nM Affinity and High Selectivity
Kristoffer Peterson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Galectin-8 induces partial epithelial-mesenchymal transition with invasive tumorigenic capabilities involving a FAK/EGFR/proteasome pathway in Madin-Darby canine kidney cells
Claudia Oyanadel et al.
MOLECULAR BIOLOGY OF THE CELL (2018)
Novel polysaccharide binding to the N-terminal tail of galectin-3 is likely modulated by proline isomerization
Michelle C. Miller et al.
GLYCOBIOLOGY (2017)
Galectin-1 Inhibitor OTX008 Induces Tumor Vessel Normalization and Tumor Growth Inhibition in Human Head and Neck Squamous Cell Carcinoma Models
Nathan A. Koonce et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
PSC-derived Galectin-1 inducing epithelial-mesenchymal transition of pancreatic ductal adenocarcinoma cells by activating the NF-κB pathway
Dong Tang et al.
ONCOTARGET (2017)
Galectin-1 knockdown improves drug sensitivity of breast cancer by reducing P-glycoprotein expression through inhibiting the Raf-1/AP-1 signaling pathway
Fang Wang et al.
ONCOTARGET (2017)
Binding of galectin-1 to integrin β1 potentiates drug resistance by promoting survivin expression in breast cancer cells
KeeSoo Nam et al.
ONCOTARGET (2017)
Triple-negative breast cancer targeting and killing by EpCAM-directed, plasmonically active nanodrug systems
Samir V. Jenkins et al.
NPJ PRECISION ONCOLOGY (2017)
Galectin-3 Inhibition by a Small-Molecule Inhibitor Reduces Both Pathological Corneal Neovascularization and Fibrosis
Wei-Sheng Chen et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2017)
Binding of polysaccharides to human galectin-3 at a noncanonical site in its carbohydrate recognition domain
Michelle C. Miller et al.
GLYCOBIOLOGY (2016)
Intra- and intermolecular interactions of human galectin-3: assessment by full-assignment-based NMR
Hans Ippel et al.
GLYCOBIOLOGY (2016)
A Selective Galactose-Coumarin-Derived Galectin-3 Inhibitor Demonstrates Involvement of Galectin-3-glycan Interactions in a Pulmonary Fibrosis Model
Vishal K. Rajput et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Galectin-1 induces hepatocellular carcinoma EMT and sorafenib resistance by activating FAK/PI3K/AKT signaling
P-F Zhang et al.
CELL DEATH & DISEASE (2016)
Galectin-1 induces invasion and the epithelial-mesenchymal transition in human gastric cancer cells via non-canonical activation of the hedgehog signaling pathway
Yang Chong et al.
ONCOTARGET (2016)
Low expression of galectin-3 is associated with poor survival in node-positive breast cancers and mesenchymal phenotype in breast cancer stem cells
Matthias Ilmer et al.
BREAST CANCER RESEARCH (2016)
Over expression of galectin-3 associates with short-term poor prognosis in stage II colon cancer
Zhiliang Huang et al.
CANCER BIOMARKERS (2016)
Galectin expression in cancer diagnosis and prognosis: A systematic review
Victor L. Thijssen et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2015)
Galectin-1 Triggers Epithelial-Mesenchymal Transition in Human Hepatocellular Carcinoma Cells
Maria L. Bacigalupo et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2015)
Targeting Artificial Tumor Stromal Targets for Molecular Imaging of Tumor Vascular Hypoxia
Nathan A. Koonce et al.
PLOS ONE (2015)
被撤回的出版物: CXCR4 Signaling Induced Epithelial-Mesenchymal Transition by PI3K/AKT and ERK Pathways in Glioblastoma(Retracted article. See vol.54,pg.2380,2017)
Baoyu Lv et al.
MOLECULAR NEUROBIOLOGY (2015)
Investigation of Galectin-3 Function in the Reproductive Tract by Identification of Binding Ligands in Human Seminal Plasma
Matthew R. Kovak et al.
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2014)
Glycosylation-Dependent Lectin-Receptor Interactions Preserve Angiogenesis in Anti-VEGF Refractory Tumors
Diego O. Croci et al.
CELL (2014)
OTX008, a selective small-molecule inhibitor of galectin-1, downregulates cancer cell proliferation, invasion and tumour angiogenesis
Lucile Astorgues-Xerri et al.
EUROPEAN JOURNAL OF CANCER (2014)
Galectin-1 links tumor hypoxia and radiotherapy
Peiwen Kuo et al.
GLYCOBIOLOGY (2014)
Galectin-1 Upregulates CXCR4 to Promote Tumor Progression and Poor Outcome in Kidney Cancer
Chang-Shuo Huang et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Lactose binding to human galectin-7 (p53-induced gene 1) induces long-range effects through the protein resulting in increased dimer stability and evidence for positive cooperativity
Elena Ermakova et al.
GLYCOBIOLOGY (2013)
Radiation-Induced Equilibrium Is a Balance between Tumor Cell Proliferation and T Cell-Mediated Killing
Hua Liang et al.
JOURNAL OF IMMUNOLOGY (2013)
Radiation-induced galectin-1 by endothelial cells: a promising molecular target for preferential drug delivery to the tumor vasculature
Meenakshi Upreti et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2013)
Galectin-3 Accelerates the Progression of Oral Tongue Squamous Cell Carcinoma via a Wnt/beta-catenin-Dependent Pathway
Li-Ping Wang et al.
PATHOLOGY & ONCOLOGY RESEARCH (2013)
Therapy of Experimental NASH and Fibrosis with Galectin Inhibitors
Peter G. Traber et al.
PLOS ONE (2013)
Regression of Fibrosis and Reversal of Cirrhosis in Rats by Galectin Inhibitors in Thioacetamide-Induced Liver Disease
Peter G. Traber et al.
PLOS ONE (2013)
Proteomic identification of galectin-3 binding ligands and characterization of galectin-3 proteolytic cleavage in human prostasomes
M. R. Kovak et al.
ANDROLOGY (2013)
Structure-Based Optimization of Angiostatic Agent 6DBF7, an Allosteric Antagonist of Galectin-1
Ruud P. M. Dings et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2013)
Structural features for α-galactomannan binding to galectin-1
Michelle C. Miller et al.
GLYCOBIOLOGY (2012)
Antitumor Agent Calixarene 0118 Targets Human Galectin-1 as an Allosteric Inhibitor of Carbohydrate Binding
Ruud P. M. Dings et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Microbeam Radiation Therapy Alters Vascular Architecture and Tumor Oxygenation and is Enhanced by a Galectin-1 Targeted Anti-Angiogenic Peptide
Robert J. Griffin et al.
RADIATION RESEARCH (2012)
A novel radioresistant mechanism of galectin-1 mediated by H-Ras-dependent pathways in cervical cancer cells
E-Y Huang et al.
CELL DEATH & DISEASE (2012)
Enhancement of T-cell-Mediated Antitumor Response: Angiostatic Adjuvant to Immunotherapy against Cancer
Ruud P. M. Dings et al.
CLINICAL CANCER RESEARCH (2011)
Structural aspects of binding of α-linked digalactosides to human galectin-1
Michelle C. Miller et al.
GLYCOBIOLOGY (2011)
Tumour thermotolerance, a physiological phenomenon involving vessel normalisation
Ruud P. M. Dings et al.
INTERNATIONAL JOURNAL OF HYPERTHERMIA (2011)
Galectin-3 ablation protects mice from diet-induced NASH: A major scavenging role for galectin-3 in liver
Carla Iacobini et al.
JOURNAL OF HEPATOLOGY (2011)
Galectin-3 Is a Substrate for Prostate Specific Antigen (PSA) in Human Seminal Plasma
Sarika Saraswati et al.
PROSTATE (2011)
Co-Purification of Mac-2 Binding Protein With Galectin-3 and Association With Prostasomes in Human Semen
Ashley S. Block et al.
PROSTATE (2011)
Inhibiting Tumor Growth by Targeting Tumor Vasculature with Galectin-1 Antagonist Anginex Conjugated to the Cytotoxic Acylfulvene, 6-Hydroxylpropylacylfulvene
Ruud P. M. Dings et al.
BIOCONJUGATE CHEMISTRY (2010)
Hypoxia inducible factor-1 mediates expression of galectin-1: the potential role in migration/invasion of colorectal cancer cells
Xu-Yun Zhao et al.
CARCINOGENESIS (2010)
Lactose Binding to Galectin-1 Modulates Structural Dynamics, Increases Conformational Entropy, and Occurs with Apparent Negative Cooperativity
Irina V. Nesmelova et al.
JOURNAL OF MOLECULAR BIOLOGY (2010)
Repression of Multiple Myeloma Growth and Preservation of Bone with Combined Radiotherapy and Anti-angiogenic Agent
Dan Jia et al.
RADIATION RESEARCH (2010)
The carbohydrate-binding domain on galectin-1 is more extensive for a complex glycan than for simple saccharides: implications for galectin-glycan interactions at the cell surface
Michelle C. Miller et al.
BIOCHEMICAL JOURNAL (2009)
Using pulse field gradient NMR diffusion measurements to define molecular size distributions in glycan preparations
Michelle C. Miller et al.
CARBOHYDRATE RESEARCH (2009)
Ovarian tumor growth regression using a combination of vascular targeting agents anginex or topomimetic 0118 and the chemotherapeutic irofulven
Ruud P. M. Dings et al.
CANCER LETTERS (2008)
A journey in structure-based drug discovery: From designed peptides to protein surface topomimetics as antibiotic and Antiangiogenic agents
Ruud P. M. Dings et al.
ACCOUNTS OF CHEMICAL RESEARCH (2007)
Scheduling of radiation with angiogenesis inhibitors anginex and avastin improves therapeutic outcome via vessel normalization
Ruud P. M. Dings et al.
CLINICAL CANCER RESEARCH (2007)
Carbohydrate-recognition domains of galectin-9 are involved in intermolecular interaction with galectin-9 itself and other members of the galectin family
Nobumitsu Miyanishi et al.
GLYCOBIOLOGY (2007)
Structure and dynamics of the full-length lipid-modified H-ras protein in a 1,2-dimyristoylglycero-3-phosphocholine bilayer
Alemayehu A. Gorfe et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Antiangiogenesis therapy using a novel angiogenesis inhibitor, anginex, following radiation causes tumor growth delay
Morikazu Amano et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2007)
Visualization of galectin-3 oligomerization on the surface of neutrophils and endothelial cells using fluorescence resonance energy transfer
Julie Nieminen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Human galectin-1,-2, and-4 induce surface exposure of phosphatidylserine in activated human neutrophils but not in activated T cells
Sean R. Stowell et al.
BLOOD (2007)
Crystal structure of the galectin-9 N-terminal carbohydrate recognition domain from Mus musculus reveals the basic mechanism of carbohydrate recognition
Masamichi Nagae et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Epigenetic regulation of tumor endothelial cell anergy:: Silencing of intercellular adhesion molecule-1 by histone modifications
Debby M. E. I. Hellebrekers et al.
CANCER RESEARCH (2006)
Galectin-1: a small protein with major functions
Isabelle Camby et al.
GLYCOBIOLOGY (2006)
Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy
Victor L. J. L. Thijssen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Screening for galectin-3 inhibitors from synthetic lacto-N-biose libraries using microscale affinity chromatography coupled to mass spectrometry
Sebastien Fort et al.
JOURNAL OF ORGANIC CHEMISTRY (2006)
Synthesis of multivalent lactose derivatives by 1,3-dipolar cycloadditions: selective galectin-1 inhibition
Johan Tejler et al.
CARBOHYDRATE RESEARCH (2006)
Design of nonpeptidic topomimetics of antiangiogenic proteins with antitumor activities
Ruud P. M. Dings et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Spatiotemporal organization of Ras signaling: Rasosomes and the galectin switch
Uri Ashery et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2006)
Galectin-1 suppresses autoimmune retinal disease by promoting concomitant Th2- and T regulatory-mediated anti-inflammatory responses
Marta A. Toscano et al.
JOURNAL OF IMMUNOLOGY (2006)
Interaction of human neutrophils with endothelial cells regulates the expression of endogenous proteins annexin 1, galectin-1 and galectin-3
CD Gil et al.
CELL BIOLOGY INTERNATIONAL (2006)
Anti-angiogenesis therapy can overcome endothelial cell anergy and promote leukocyte-endothelium interactions and infiltration in tumors
Anita E. M. Dirkx et al.
FASEB JOURNAL (2006)
Galectin-3 regulates myofibroblast activation and hepatic fibrosis
NC Henderson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Aryl O- and S-galactosides and lactosides as specific inhibitors of human galectins-1 and -3:: Role of electrostatic potential at O-3
D Giguère et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Synthetic lactulose amines: novel class of anticancer agents that induce tumor-cell apoptosis and inhibit galectin-mediated homotypic cell aggregation and endothelial cell morphogenesis
GA Rabinovich et al.
GLYCOBIOLOGY (2006)
Thioureido N-acetyllactosamine derivatives as potent galectin-7 and 9N inhibitors
BA Salameh et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2006)
Carbohydrate triazoles and isoxazoles as inhibitors of galectins-1 and -3
Denis Giguere et al.
CHEMICAL COMMUNICATIONS (2006)
Anti-galectin compounds as potential anti-cancer drugs
Laurent Ingrassia et al.
CURRENT MEDICINAL CHEMISTRY (2006)
Galectin-1: A link between tumor hypoxia and tumor immune privilege
QT Le et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study
M Nordsmark et al.
RADIOTHERAPY AND ONCOLOGY (2005)
Structural basis of a fungal galectin from Agrocybe cylindracea for recognizing sialoconjugate
M Ban et al.
JOURNAL OF MOLECULAR BIOLOGY (2005)
3-(1,2,3-Triazol-1-yl)-1-thio-galactosides as small, efficient, and hydrolytically stable inhibitors of galectin-3
BA Salameh et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
Local radiation therapy of B16 melanoma tumors increases the generation of tumor antigen-specific effector cells that traffic to the tumor
AA Lugade et al.
JOURNAL OF IMMUNOLOGY (2005)
Insights into the role of the aromatic residue in galactose-binding sites: MP2/6-311G++** study on galactose- and glucose-aromatic residue analogue complexes
MS Sujatha et al.
BIOCHEMISTRY (2005)
Anginex synergizes with radiation therapy to inhibit tumor growth by radiosensitizing endothelial cells
RPM Dings et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Structural and functional studies of galectin-1: A novel axonal regeneration-promoting activity for oxidized galectin-1
T Kadoya et al.
CURRENT DRUG TARGETS (2005)
Synthesis of O-galactosyl aldoximes as potent LacNAc-mimetic galectin-3 inhibitors
J Tejler et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
Galectin-1 as a potential cancer target
GA Rabinovich
BRITISH JOURNAL OF CANCER (2005)
In vitro evolutionary thermostabilization of congerin II:: A limited reproduction of natural protein evolution by artificial selection pressure
C Shionyu-Mitsuyama et al.
JOURNAL OF MOLECULAR BIOLOGY (2005)
Determination of structural and functional overlap/divergence of five proto-type galectins by analysis of the growth-regulatory interaction with ganglioside GM1 in silico and in vitro on human neuroblastoma cells
S André et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Dimeric galectin-1 binds with high affinity to α2,3-sialylated and non-sialylated terminal N-acetyllactosamine units on surface-bound extended glycans
A Leppänen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Structural and thermodynamic studies on cation -: II: interactions in lectin-ligand complexes:: High-affinity galectin-3 inhibitors through fine-tuning of an arginine-arene interaction
P Sörme et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2005)
Peptides specific to the galectin-3 carbohydrate recognition domain inhibit metastasis-associated cancer cell adhesion
J Zou et al.
CARCINOGENESIS (2005)
Galectins as modulators of tumour progression
FT Liu et al.
NATURE REVIEWS CANCER (2005)
Synthesis of a phenyl thio-beta-D-galactopyranoside library from 1,5-difluoro-2,4-dinitrobenzene: discovery of effcient and selective monosaccharide inhibitors of galectin-7
I Cumpstey et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2005)
C-2-symmetrical thiodigalactoside bis-benzamido derivatives as high-affinity inhibitors of galectin-3: efficient lectin inhibition through double arginine-arene interactions
I Cumpstey et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2005)
Structure and functional analysis of the fungal galectin CGL2
PJ Walser et al.
STRUCTURE (2004)
Galectin-3 precipitates as a pentamer with synthetic multivalent carbohydrates and forms heterogeneous cross-linked complexes
N Ahmad et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection: A potential mechanism of tumor-immune privilege
N Rubinstein et al.
CANCER CELL (2004)
Quaternary solution structures of galectins-1,-3, and-7
S Morris et al.
GLYCOBIOLOGY (2004)
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
CG Willett et al.
NATURE MEDICINE (2004)
Growth-regulatory human galectin-1:: Crystallographic characterisation of the structural changes induced by single-site mutations and their impact on the thermodynamics of ligand binding
MF López-Lucendo et al.
JOURNAL OF MOLECULAR BIOLOGY (2004)
Functional variation in LGALS2 confers risk of myocardial infarction and regulates lymphotoxin-α secretion in vitro
K Ozaki et al.
NATURE (2004)
Galectin-1β, a natural monomeric form of galectin-1 lacking its six amino-terminal residues promotes axonal regeneration but not cell death
T Miura et al.
CELL DEATH AND DIFFERENTIATION (2004)
Galectin-1(L11A) predicted from a computed galectin-1 farnesyl-binding pocket selectively inhibits Ras-GTP
B Rotblat et al.
CANCER RESEARCH (2004)
Design of a partial peptide mimetic of anginex with antiangiogenic and anticancer activity
KH Mayo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
β-sheet is the bioactive conformation of the anti-angiogenic anginex peptide
RPM Dings et al.
BIOCHEMICAL JOURNAL (2003)
Anti-tumor activity of the novel angiogenesis inhibitor anginex
RPM Dings et al.
CANCER LETTERS (2003)
Nuclear localization of Galectin-3 in transformed thyroid cells: a role in transcriptional regulation
I Paron et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Galectins-3 and-7, but not galectin-1, play a role in re-epithelialization of wounds
ZY Cao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Clusters, bundles, arrays and lattices: novel mechanisms for lectin-saccharide-mediated cellular interactions
CF Brewer et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2002)
Galectinomics: finding themes in complexity
DNW Cooper
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2002)
Oligosaccharide specificity of galectins: a search by frontal affinity chromatography
J Hirabayashi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2002)
Intracellular functions of galectins
FT Liu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2002)
Crystal structure of a conger eel galectin (Congerin II) at 1.45 Å resolution:: Implication for the accelerated evolution of a new ligand-binding site following gene duplication
T Shirai et al.
JOURNAL OF MOLECULAR BIOLOGY (2002)
Thermodynamic binding studies of cell surface carbohydrate epitopes to galectins-1,-3, and-7:: Evidence for differential binding specificities
N Ahmad et al.
CANADIAN JOURNAL OF CHEMISTRY (2002)
Galectin-3 translocates to the perinuclear membranes and inhibits cytochrome c release from the mitochondria -: A role for synexin in galectin-3 translocation
F Yu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
fosB gene products trigger cell proliferation and morphological alteration with an increased expression of a novel processed form of galectin-1 in the rat 3Y1 embryo cell line
T Nishioka et al.
JOURNAL OF BIOCHEMISTRY (2002)
Charcot-Leyden crystal protein (galectin-10) is not a dual function galectin with lysophospholipase activity but binds a lysophospholipase inhibitor in a novel structural fashion
SJ Ackerman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
High-affinity binding of recombinant human galectin-4 to SO3--> 3Gal beta 1 -> 3GalNAc pyranoside
H Ideo et al.
GLYCOBIOLOGY (2002)
Galectin-1 binds oncogenic H-Ras to mediate Ras membrane anchorage and cell transformation
A Paz et al.
ONCOGENE (2001)
Comprehensive galectin fingerprinting in a panel of 61 human tumor cell lines by RT-PCR and its implications for diagnostic and therapeutic procedures
H Lahm et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2001)
Regulation of glut1 mRNA by hypoxia-inducible factor-1 -: Interaction between H-ras and hypoxia
CH Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Molecular characterization of prostate carcinoma tumor antigen-1, PCTA-1, a human Galectin-8 related gene
RV Gopalkrishnan et al.
ONCOGENE (2000)
Structure of the Rho family GTP-binding protein Cdc42 in complex with the multifunctional regulator RhoGDI
GR Hoffman et al.
CELL (2000)
Share Paper
